Clinical trials
Esophageal Squamous Cell Carcinoma trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 8 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Chinese Academy of Medical Sciences | 2 |
| Peking University | 2 |
| RenJi Hospital | 2 |
| Shanghai Zhongshan Hospital | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| Xijing Hospital of Digestive Diseases | 2 |
| Anhui Provincial Hospital | 1 |
| Changhai Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 31 |
| Esophageal Neoplasms | 4 |
| Biliary Tract Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Gastrointestinal Neoplasms | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Hypersensitivity | 1 |
| Neoplasms, Unknown Primary | 1 |
| Neuroendocrine Tumors | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.